CN104906527A - Traditional Chinese medicine composition for treating infantile asthma - Google Patents
Traditional Chinese medicine composition for treating infantile asthma Download PDFInfo
- Publication number
- CN104906527A CN104906527A CN201410091829.7A CN201410091829A CN104906527A CN 104906527 A CN104906527 A CN 104906527A CN 201410091829 A CN201410091829 A CN 201410091829A CN 104906527 A CN104906527 A CN 104906527A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- infantile asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating infantile asthma. The traditional Chinese medicine composition is a medicament prepared from the following raw medicinal materials, by weight, 1-20 parts of whole herb of folium pyrrosiae, 1-10 parts of lumbricus, 1-5 parts of ginger, 1-5 parts of rock sugar and 1-10 parts of biota orientalis. The traditional Chinese medicine composition has a reasonable formula, has definite curative effects and can be used for effectively treating infantile asthma.
Description
Technical field
The present invention relates to tcm field, specifically, relate to a kind of Chinese medicine composition for the treatment of infantile asthma.
Background technology
Infantile asthma is the common chronic respiratory tract disease of child, and its sickness rate of China in recent years, ascendant trend is more violent.Shangguan is sharp waits people to treat bronchial asthma with Folium Pyrrosiae, [journal of shanghai Chinese medicine 1965:(2): 18], but its curative effect reduces gradually in recent years.Research shows, the Major Risk Factors of present infantile asthma has family's allergies, house decoration history, passive smoking and early application antibiotic [Chinese Journal of Contemporary Pediatrics, 2013,15 (11): 979-982].
Due to the normal recurrent exerbation of asthma, doctor trained in Western medicine is difficult to radical cure, has a strong impact on the physical and mental health of infant, also brings heavy financial burden and stress to infants ' parents; Prevent and treat asthma at present, extremely urgent from children's period.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of infantile asthma.
In order to overcome above-mentioned deficiency, realizing object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of infantile asthma, it is characterized in that, it is the medicament be made up by weight of following bulk drugs:
[0006] Folium Pyrrosiae herb 1 ~ 20 part, Pheretima 1 ~ 10 part, 1 ~ 5 part, Rhizoma Zingiberis Recens, 1 ~ 5 part, crystal sugar, Cacumen Platycladi 1 ~ 10 part.
Preferably, the medicament be made up by weight of following bulk drugs of Chinese medicine composition of the present invention:
[0010] Folium Pyrrosiae herb 18 parts, Pheretima 6 parts, 6 parts, Rhizoma Zingiberis Recens, 2 parts, crystal sugar, Cacumen Platycladi 9 parts.
Chinese medicine composition of the present invention, can make various dosage form with pharmaceutically acceptable carrier, such as decoction, tablet, capsule, soft capsule, pill, granule, drop pill or an intestinal agent etc.Preparation technique means well known in the art can be adopted to complete the preparation of Chinese medicine composition of the present invention.
Described pharmaceutically acceptable carrier is well known, for for the preparation of the usual excipients of above-mentioned preparation or adjuvant.Conventional excipient or adjuvant comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant etc., such as, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate etc.
The determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs of Chinese medicine composition of the present invention, reasonable recipe, clear curative effect, can treat infantile asthma effectively.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
[0018] Folium Pyrrosiae herb 18 parts, Pheretima 6 parts, 6 parts, Rhizoma Zingiberis Recens, Cacumen Platycladi 9 parts, add the water of 10 times of medical material weight, at 80 DEG C heat 2 hours, filter, add 2 parts, crystal sugar while hot, filtrate be concentrated into 200 milliliters, obtain final product.
Experimental example diagnostic criteria
The cough variant asthma diagnostic criteria of formulating according to national pediatric asthma cooperative groups in 1998 (national pediatric asthma control association group. pediatric asthma control conventional (trying). Pediatrics magazine, 1998,36 (12); 747.) judge: cough continues or recurrent exerbation is mixed 30 days, normal companion's night or ictal cough in early morning, expectorant is few, and motion increases the weight of; Clinical nothing infects sign or long-term antibiotic therapy is invalid; Coughing fit can be made to alleviate by bronchodilator; Except the chronic cough that causes of other reasons; A guy or family's allergies, measurement of bronchial responsiveness, allergen detection etc. can make auxiliary diagnosis.
The all selected patients of physical data are divided into two groups at random: (1) treatment group 35 example, wherein, and man 19 example, female 16 example, max age 13 years old, minimum June, average 7.6 years old ,-6 years Mays of the course of disease, average 4.7 years; (2) matched group 35 example, wherein, man 17 example, female 18 example, max age 12 years old, minimum JIUYUE, average 4.9 years old, in-7 years June of the course of disease, average 6.9 years, two groups of patients all met diagnostic criteria; Two groups of severity extents, sex, age equal no significant differences.
Therapeutic Method treatment group takes the decoction of preparation in embodiment 1, takes 4 every day, each 1 ml/kg.It within 2 weeks, is 1 course for the treatment of.Matched group: Roxithromycin (1) body weight 24 ~ 40kg child, a 100mg, 2 times on the one; (2) 12 ~ 23kg children, a 50mg, 2 times on the one; (3). infant: by body weight 2.5 ~ 5mg/kg, 2 times on the one.
Criterion of therapeutical effect formulate according to Department of Medical Administration of State Administration of Traditional Chinese Medicine criterion of therapeutical effect (Department of Medical Administration of State Administration of Traditional Chinese Medicine. Gynecology & Pediatrics Dept. disease Standardization of diagnosis and curative effect inside and outside the traditional Chinese medical science. Nanjing: Jiangsu science tech publishing house, 1998,136.): clinical cure: cough and pharyngeal transference cure, within more than 2 weeks, do not send out again; Take a turn for the better: symptom alleviates; Invalid: symptom is not improved.
Therapeutic outcome: add up curative effect after treating two courses for the treatment of.Treatment group 35 example, wherein effective 20 examples (57.14%), 12 examples that take a turn for the better (34.29%), invalid: 3 examples (8.57%), total effective rate reaches 91.43%; Matched group 35 example, effective: 15 examples (42.86%), take a turn for the better: 12 examples (28.57%), invalid 8 examples (22.86%), total effective rate 77.14%.
Claims (2)
1. treat the pharmaceutical composition of infantile asthma for one kind, it is characterized in that, it is the medicament be made up by weight of following bulk drugs: Folium Pyrrosiae herb 1 ~ 20 part, Pheretima 1 ~ 10 part, 1 ~ 5 part, Rhizoma Zingiberis Recens, 1 ~ 5 part, crystal sugar, Cacumen Platycladi 1 ~ 10 part.
2. according to the pharmaceutical composition of the treatment infantile asthma described in claim 1, it is characterized in that, it is the medicament be made up by weight of following bulk drugs: Folium Pyrrosiae herb 18 parts, Pheretima 6 parts, 6 parts, Rhizoma Zingiberis Recens, 2 parts, crystal sugar, Cacumen Platycladi 9 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410091829.7A CN104906527A (en) | 2014-03-13 | 2014-03-13 | Traditional Chinese medicine composition for treating infantile asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410091829.7A CN104906527A (en) | 2014-03-13 | 2014-03-13 | Traditional Chinese medicine composition for treating infantile asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104906527A true CN104906527A (en) | 2015-09-16 |
Family
ID=54076244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410091829.7A Pending CN104906527A (en) | 2014-03-13 | 2014-03-13 | Traditional Chinese medicine composition for treating infantile asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104906527A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356915A (en) * | 2013-07-19 | 2013-10-23 | 苏州市天灵中药饮片有限公司 | Decoction for treatment of asthma |
| CN103705849A (en) * | 2013-12-27 | 2014-04-09 | 王法红 | Traditional Chinese medicine for treating bronchial asthma |
-
2014
- 2014-03-13 CN CN201410091829.7A patent/CN104906527A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356915A (en) * | 2013-07-19 | 2013-10-23 | 苏州市天灵中药饮片有限公司 | Decoction for treatment of asthma |
| CN103705849A (en) * | 2013-12-27 | 2014-04-09 | 王法红 | Traditional Chinese medicine for treating bronchial asthma |
Non-Patent Citations (4)
| Title |
|---|
| 上官锐: "用石韦治疗支气管哮喘", 《上海中医药杂志》 * |
| 王烈: "小儿哮喘通论", 《全国第26届中医儿科学术会暨王烈教授学术思想研讨会论文集》 * |
| 王素平: "小儿支气管哮喘的中药治疗近况", 《实用中医药杂志》 * |
| 肖凤双等: "蝉蜕治疗咳喘症临床应用举隅", 《河北中医药学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101700307B (en) | Traditional Chinese medicine for curing chronic pharyngolaryngitis | |
| CN103211997A (en) | Antibacterial and antiviral traditional Chinese medicine composition and preparation method thereof | |
| CN106361993A (en) | Medicinal composition for preventing and treating gastric mucosal lesion and preparation method of medicinal composition | |
| CN104189110B (en) | A kind of Chinese medicine composition for the treatment of influenza and preparation method thereof | |
| CN102488801B (en) | Medicine composition for curing chronic gastritis | |
| CN105250843A (en) | Medicament for treating cough due to wind-heat evil | |
| CN102319295B (en) | Medicament for treating upper respiratory tract infection | |
| CN103432506B (en) | Pharmaceutical composition for treating upper respiratory infection | |
| CN104189291A (en) | Traditional Chinese medicine composition for treating upper respiratory infection | |
| CN103830481B (en) | The medicine for the treatment of infantile respiratory tract infection repeatedly | |
| CN102488788B (en) | Medicinal composition for treating asthma in children | |
| CN104906527A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN103550459B (en) | A kind of preparation method for the treatment of the medicament of infantile asthma | |
| CN103463517A (en) | Medicament for treating asthma | |
| CN103463537B (en) | Medicament for treating infantile asthma | |
| CN102688405A (en) | Bulbus fritillariae cirrhosae traditional Chinese medicine decoction for treating cough and preparation method | |
| CN102670819B (en) | Medicine composition for treating cold | |
| CN106491692A (en) | A kind of coldrex | |
| CN103463401B (en) | Asthma medicine for infants | |
| CN102512652B (en) | Medicinal composition for treating peptic ulcer | |
| CN103520386B (en) | Preparation method of medicine composition used for treating children asthma | |
| CN101607035A (en) | A kind of pharmaceutical composition that is used for the treatment of infantile acute bronchitis | |
| CN1331485C (en) | Medicine for treating cold | |
| CN106031781A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN104055886A (en) | Medicinal composition for treating chronic cough, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150916 |
|
| WD01 | Invention patent application deemed withdrawn after publication |